期刊文献+

Survivin基因在三氧化二砷诱导腺样囊性癌-M细胞凋亡中的作用 被引量:2

Role of Survivin Gene on the Apoptosis of Adenoid Cystic Carcinoma-M Cells Induced by Arsenic Trioxide
暂未订购
导出
摘要 目的:体外观察三氧化二砷(As2O3)诱导人类腺样囊性癌高转移株(ACC-M)细胞凋亡过程中的作用,同时检测此过程中ACC-M内凋亡抑制基因Survivin表达水平的变化。方法:MTT法检测不同浓度As2O3作用不同时间对ACC-M细胞的抑制效应;流式细胞术观察As2O3诱导各组ACC-M细胞的凋亡率。RT-PCR检测Survivin基因mRNA的表达变化;Western blot检测判定Survivin蛋白水平的表达差异。结果:As2O3可明显抑制ACC-M细胞的生长,其抑制率呈浓度和时间依赖关系,细胞凋亡率也呈相同的趋势。RT-PCR和Western blot检测显示As2O3作用下,ACC-M内Survivin mRNA和蛋白表达明显受抑制,抑制程度也具有时间和剂量依赖性。结论:As2O3可通过促进细胞凋亡的方式使体外培养的ACC-M细胞生长受抑制,而受抑制的ACC-M内Survivin mRNA和蛋白表达均下降,推测Survivin基因在As2O3诱导的ACC-M细胞凋过程中起着重要作用。 Objective: To investigate the proliferation inhibition of arsenic trioxide(As2O3) on salivary adenoid cystic carcinma-M(ACC-M) cells in vitro and to study the role of Survivin on the apoptosis of ACC-M induced by As2O3.Methods: ACC-M cells were treated with different concentration of As2O3 for different periods.The inhibitory effects on cell's growth were assayed with MTT test.Apoptosis was determined by flow cytometry.The expression of Survivin mRNA and protein were investigated by RT-PCR and Western blot analysis respectively.Results: Cell viability after As2O3 treatment was markedly suppressed and exhibited as a dose-and time-dependent pattern.The apoptotic index showed the similar trend.The results of RT-PCR revealed gene expression of Survivin was suppressed significantly.Through Western blot analysis,a negative correlation between concentration and amount of protein product of Survivin was determined.Conclusion: As2O3 might markedly suppressed ACC-M cell's viability in vitro.The inhibition of Survivin gene expression may play a critical role on ACC-M cell apoptosis induced by As2O3.
出处 《口腔医学研究》 CAS CSCD 北大核心 2011年第10期911-914,共4页 Journal of Oral Science Research
关键词 三氧化二砷 腺样囊性癌-M 细胞凋亡 SURVIVIN Arsenic trioxide Adenoid cystic carcinoma Apoptosis Survivin
  • 相关文献

参考文献5

二级参考文献23

  • 1Yan-Feng Xiao,Shan-Xi Liu,De-Dong Wu,Xi Chen,Li-Fen Ren.Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer[J].World Journal of Gastroenterology,2006,12(36):5780-5786. 被引量:48
  • 2Mckenzie EA. Heparanase: a target for drug discovery in cancer and inflammation [J]. British journal of Pharmacology, 2007 , 151(1): 1-14.
  • 3Cohen E, Atzmon R, Vlodavsky I, et al. Heparanase processing by lysosomal/ endosomal protein preparation [J]. FEBS Lett , 2005, 579(11) : 2334-2338.
  • 4Vlodavsky I, Goldshmidt O, Zcharia E. et al. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development [J]. Semin Cancer Bioh 2002, 12(2) 121-129.
  • 5Cai YG, Fang DC , Chen L, et at. Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T- cell responses against gastric cancer tumor cells in vitro [J] Tumor Biol, 2007, 28 :238-246.
  • 6El -Assal ON, Yamanoi A, Ono T, et al. The clinic pathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma [J]. Clin Cancer Res, 2001, 7(5):1299-1305.
  • 7Walch ET, Albino AP, Marchett TD. Correlation of over expression of the low affinity p75 neurotrophin receptor with augmented invasion and heparanase in human malignant melanoma cells [J]. Int J Caner, 1999, 82(1) : 112- 120.
  • 8Marchetti D, Reiland J, Erwin B, et al. Inhibition of heparanase activity and heparanase--induced angiogenesis by suramin analogues [J]. Int J Cancer , 2003 ,104(2) : 167-174.
  • 9陈国强,中华血液学杂志,1997年,18卷,25页
  • 10Chang K S,Blood,1995年,85卷,3646页

共引文献80

同被引文献29

  • 1YanJIN YongWEI LeiXIONG YingYANG JiaRuiWU.Differential regulation of survivin by p53 contributes to cell cycle dependent apoptosis[J].Cell Research,2005,15(5):361-370. 被引量:21
  • 2李晓光,高慎强,张晓红,王延秀,亓春花,李宁.涎腺腺癌COX-2表达和肿瘤血管生成的研究[J].重庆医学,2006,35(8):707-709. 被引量:2
  • 3李晓光,高德安,张丽,王延秀,杨宪勇,王青.口腔鳞癌COX-2表达和肿瘤血管生成的研究[J].北京口腔医学,2006,14(3):164-166. 被引量:5
  • 4邱蔚六.口腔颌面外科学[M].第5版.北京:人民卫生出版社,2007:186-197.
  • 5Mendenhall WM, Werning JW, Fernandes R,et al.Amelo-blastoma [J].Am J Clin Oncol,2007,30(6) : 645 - 648.
  • 6Kruse AL, Zwahlen RA, Gratz KW.New classification ofmaxillary ameloblastic carcinoma based on an evidence -based literature review over the last 60 years [J], Head NeckOncol, 2009,1 : 31.
  • 7Gomes CC, Duarte AP, Diniz MG, et al.Current concepts ofameloblastoma pathogenesis [J].J Oral Pathol Med, 2010,39(8) : 585-591.
  • 8Duffya NJ, CVDonovanc N, Brennan DJ, et al.Survivin: Apromising tumor biomarker [J].Cancer Letters, 2007,249(1): 49-60.
  • 9Kumamoto H, Ooya K.Expression of survivin and X chro-mosome- linked inhibitor of apoptosis protein in ameloblas-tomas [J].Virchows Arch, 2004, 444(2) :164 - 170.
  • 10Kumamoto H, Ooya K.Detection of mitochondria mediatedapoptosis signaling molecules in ameloblastomas [J].J OralPathol Med, 2005,34(9) : 565 - 572.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部